Pharmacotherapy with benzodiazepines: Basic facts and recent developments;Pharmakotherapie mit benzodiazepinen: Grundlagen und neue Entwicklungen

Praxis

Volumn 87, Issue 6, 1998, Pages 186-190

  Mohler H ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Benzodiazepines; Epilepsy anxiety; GABA(A) receptor; GABA(B) receptor; Insomnia

Indexed keywords

ALPRAZOLAM; BACLOFEN; BELLERGAL; BROMAZEPAM; BROTIZOLAM; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; GABAPENTIN; LORAZEPAM; LORMETAZEPAM; MIDAZOLAM; MIDAZOLAM MALEATE; NITRAZEPAM; OXAZEPAM; PRAZEPAM; PROPOFOL; TEMAZEPAM; THIOPENTAL; TIAGABINE; TOPIRAMATE; TRIAZOLAM; VALPROIC ACID; VIGABATRIN; ZOLPIDEM TARTRATE; ZOPICLONE;

ANTICONVULSANT ACTIVITY; ANXIETY NEUROSIS; DRUG RECEPTOR BINDING; EPILEPSY; HUMAN; INSOMNIA; NEUROTRANSMITTER RELEASE; RECEPTOR AFFINITY; REVIEW; SYNAPTIC TRANSMISSION;

EID: 0032481415     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Wieser H. G.: Behandlung der Epilepsien: Wo stehen wir heute? Schweiz. Rundschau Med. Prax. 1996; 85: 74-79.
2. B receptors. In: S.J Enna and N.G. Bowery eds., The GABA-receptors. 2nd edition 1997; Humana pp. 209-236.
3. Möhler H.: GABAergic synaptic transmission. Arzneimittelforschung/Drug Res. 1992; 42: 211-214.
4. A-receptors. In: S.J. Enna and N. G. Bowery eds., The GABA-receptors, 2nd edition 1997; Humana pp. 11-36.
5. Rudolph U., Möhler H. et al. (in Vorbereitung)
6. Wood J. H., Winger G.: Current benzodiazepine issues. Psychopharmacology 1995; 118: 107-115.
7. Shader R. I., Greenblatt D. J.: Use of benzodiazepines in anxiety disorders. New Engl J Med 1993; 328: 1398-1405.
8. Borbély A.A.: Pharmakotherapie von Schlafstörungen mit Benzodiazepinhypnotika und Analoga. Praxis 1995: 84: 722-725.